Published Papers & Misc - SHIMIZU Masaki

Division display  201 - 220 of about 271 /  All the affair displays >>
  1. Inoue N, Shimizu M, Tsunoda S, Kawano M, Matsumura M, Yachie A. Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis. Clinical immunology (Orlando, Fla.). 2016.08; 169 8-13. ( PubMed, DOI )

  2. Ueno K, Shimizu M, Kubo T, Igarashi N, Hatasaki K. An infant with nephrolithiasis and renal failure: Answers. Pediatric nephrology (Berlin, Germany). 2016.07; 31 (7): 1083-4. ( PubMed, DOI )

  3. Inoue N, Mizuta M, Shimizu M. Clinical Usefulness of 18F-fluorodeoxyglucose Positron Emission Tomography for Enthesitis-related Arthritis Diagnosis. The Journal of rheumatology. 2016.07; 43 (7): 1434-5. ( PubMed, DOI )

  4. Ueno K, Shimizu M, Kubo T, Igarashi N, Hatasaki K. An infant with nephrolithiasis and renal failure: Questions. Pediatric nephrology (Berlin, Germany). 2016.07; 31 (7): 1081-2. ( PubMed, DOI )

  5. Nakagishi Y, Shimizu M, Kasai K, Miyoshi M, Yachie A. Successful therapy of macrophage activation syndrome with dexamethasone palmitate. Modern rheumatology. 2016.07; 26 (4): 617-20. ( PubMed, DOI )

  6. Shimizu M, Inoue N, Mizuta M, Ikawa Y, Yachie A. Leopard skin appearance of cutaneous polyarteritis nodosa on 18Ffluorodeoxyglucose positron emission tomography. Rheumatology (Oxford, England). 2016.06; 55 (6): 1090. ( PubMed, DOI )

  7. Sawai T, Shimizu M, Sakai T, Yachie A. Tubulointerstitial Nephritis and Uveitis Syndrome Associated With Human Papillomavirus Vaccine. Journal of pediatric ophthalmology and strabismus. 2016.05; 53 (3): 190-1. ( PubMed, DOI )

  8. Tasaki Y, Shimizu M, Inoue N, Mizuta M, Nakagishi Y, Wada T, Yachie A. Disruption of vascular endothelial homeostasis in systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: The dynamic roles of angiopoietin-1 and -2. Cytokine. 2016.04; 80 1-6. ( PubMed, DOI )

  9. Yokoyama K, Shimizu M, Yoshida A. Femoral Agminated Petechiae Associated with Acute Parvovirus B19 Infection. The Pediatric infectious disease journal. 2016.02; 35 (2): 228-9. ( PubMed, DOI )

  10. Tajiri H, Nishi J, Ushijima K, Shimizu T, Ishige T, Shimizu M, Tanaka H, Brooks S. A role for fosfomycin treatment in children for prevention of haemolytic-uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection. International journal of antimicrobial agents. 2015.11; 46 (5): 586-9. ( PubMed, DOI )

  11. Shimizu M, Nakagishi Y, Inoue N, Mizuta M, Ko G, Saikawa Y, Kubota T, Yamasaki Y, Takei S, Yachie A. Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Clinical immunology (Orlando, Fla.). 2015.10; 160 (2): 277-81. ( PubMed, DOI )

  12. Takakura M, Shimizu M, Inoue N, Tasaki Y, Ishikawa S, Ohta K, Yachie A. Iodine-induced non-autoimmune hypothyroidism in a patient with steroid-resistant nephrotic syndrome. Pediatrics international : official journal of the Japan Pediatric Society. 2015.10; 57 (5): 1055-6. ( PubMed, DOI )

  13. Sugimoto N, Leu H, Inoue N, Shimizu M, Toma T, Kuroda M, Saito T, Wada T, Yachie A. The critical role of lipopolysaccharide in the upregulation of aquaporin 4 in glial cells treated with Shiga toxin. Journal of biomedical science. 2015.09; 22 78. ( PubMed, DOI )

  14. Kuroda M, Shimizu M, Inoue N, Ikeno I, Nakagawa H, Yokoi A, Niida Y, Konishi M, Kaneda H, Igarashi N, Yamahana J, Taneichi H, Kanegane H, Ito M, Saito S, Furuichi K, Wada T, Nakagawa M, Yokoyama H, Yachie A. Serum tau protein as a marker of disease activity in enterohemorrhagic Escherichia coli O111-induced hemolytic uremic syndrome. Neurochemistry international. 2015.06; 85-86 24-30. ( PubMed, DOI )

  15. Shimizu M, Sakai S, Ohta K, Miyamoto M, Yachie A. Uterus didelphys with obstructed hemivagina and contralateral multicystic dysplastic kidney. CEN case reports. 2015.05; 4 (1): 61-64. ( PubMed, DOI )

  16. Ueno K, Shimizu M, Yokoyama T, Ishikawa S, Tasaki Y, Inoue N, Sugimoto N, Ohta K, Yachie A. Urinary neopterin: an immune activation marker in mesangial proliferative glomerulonephritis. Clinical and experimental nephrology. 2015.04; 19 (2): 264-70. ( PubMed, DOI )

  17. Takahara T, Shimizu M, Nakagishi Y, Kinjo N, Yachie A. Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease. Rheumatology international. 2015.01; 35 (1): 81-4. ( PubMed, DOI )

  18. Yokoyama T, Sugimoto N, Kato E, Ohta K, Ishikawa S, Ueno K, Shimizu M, Yachie A. Rotavirus gastroenteritis-associated urinary ammonium acid urate crystals. Pediatrics international : official journal of the Japan Pediatric Society. 2015; 57 (1): 158-60. ( PubMed, DOI )

  19. Shimizu M, Hamaguchi Y, Ishikawa S, Ueno K, Yachie A. Successful treatment with tocilizumab of a psoriasiform skin lesion induced by etanercept in a patient with juvenile idiopathic arthritis. Modern rheumatology. 2015; 25 (6): 972-3. ( PubMed, DOI )

  20. Shimizu M, Nakagishi Y, Yoshida A, Yachie A. Serum interleukin 18 as a diagnostic remission criterion in systemic juvenile idiopathic arthritis. The Journal of rheumatology. 2014.11; 41 (11): 2328-30. ( PubMed, DOI )

To the head of this page.▲